My Financial News from South Africa, Savings

from Bing and Google News
South Africa , Thursday 16 April 2026

South Africa’s antitrust regulator wants Roche penalized for ‘excessive’ cancer drug pricing

Published on: Tuesday 08 February 2022

South Africa’s antitrust regulator has recommended that Roche (RHHBY) should be penalized for allegedly “excessive” pricing of its Herceptin breast cancer treatment, arguing it violates basic human ...



Share this news on:  

RELATED NEWS